Moody’s rates GoodRx loans B1

Moody’s Investors Service said it gave B1 ratings to GoodRx Holding Inc.’s new seven-year backed senior secured first-lien term loan B and newly extended backed senior secured first-lien revolving credit facility.

The agency concurrently affirmed GoodRx’s B1 corporate family rating and B1-PD probability of default rating. The SGL-1 speculative grade liquidity rating is unchanged.

GoodRx plans to repay its $700 million term loan and $100 million revolver. Both rated B1.

“The proposed refinancing of the term loan and extension of the revolver to October 2029 are credit positive and supportive of GoodRx's liquidity while leverage neutral. Moody's plans to withdraw the ratings of the existing term loan and revolving credit facility upon completion of the refinancing transaction,” Moody’s said in a press release.

The outlook remains stable.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.